Megha Manchanda &Amp;Amp; Sohini Das

Stories by Megha Manchanda &Amp;Amp; Sohini Das

How companies deal with coronavirus panic

How companies deal with coronavirus panic

Rediff.com   17 Mar 2020

Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.

Coronavirus fear robs malls, multiplexes of Holi colour

Coronavirus fear robs malls, multiplexes of Holi colour

Rediff.com   8 Mar 2020

'There is a clear business impact. People are avoiding crowded places and gatherings across cities. This is hitting business, both at traditional and modern trade outlets, during the Holi season, which kicked off from Saturday,' says Praveen Khandelwal, general secretary, Confederation of All India Traders (CAIT).

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com   4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com   20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Kohli is top celebrity brand for third time in a row

Kohli is top celebrity brand for third time in a row

Rediff.com   17 Feb 2020

The Duff & Phelps report shows that Virat Kohli has increased his brand value by 40 per cent to $237.5 million in 2019 and taken a huge lead with his closest rival, Akshay Kumar, ranked second.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com   12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

India to get 13th major port at Vadhavan in Maharashtra

India to get 13th major port at Vadhavan in Maharashtra

Rediff.com   7 Feb 2020

With development of the Vadhavan port, India will break into the countries with top 10 container ports in the world.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

Gadkari keen to fast-track highway projects

Gadkari keen to fast-track highway projects

Rediff.com   23 Jan 2020

Various stakeholders, including about 600 developers, bankers and officials from various wings, including the National Highways Authority of India, will also be present.

Adamant Trai says will implement new tariff order by March 1

Adamant Trai says will implement new tariff order by March 1

Rediff.com   14 Jan 2020

Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com   13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

Post-VRS, a leaner BSNL is all set for 4G services

Post-VRS, a leaner BSNL is all set for 4G services

Rediff.com   7 Jan 2020

The company, which has a subscriber base of 120 million, also plans to raise funds via a bonds issue. The company's impending 4G launch is also expected in the second half of the current financial year for which it would invest Rs 12,000 crore, partly through bonds.

How Avengers stole the Indian box office

How Avengers stole the Indian box office

Rediff.com   1 Jan 2020

'If you look at the Number 1 film in India this year across Bollywood and other regional film industries, it is Avengers: Endgame.'

Huawei can now participate in 5G trials in India

Huawei can now participate in 5G trials in India

Rediff.com   31 Dec 2019

Huawei came under a cloud after allegations that the firm's electronic and telecom devices helped China spy on US corporations and agencies.

BOT share in highways seen shrinking

BOT share in highways seen shrinking

Rediff.com   27 Dec 2019

As even bigger road construction players are not willing to bet on BOT projects., NHAI will have to rethink its thrust on the BOT model.

No cut in spectrum price as govt okays airwave auction

No cut in spectrum price as govt okays airwave auction

Rediff.com   21 Dec 2019

Although the industry is disappointed with the government decision not to lower spectrum prices at a time telcos are saddled with over Rs 4-trillion debt and an estimated Rs 1.43-trillion licence fee dues, the DCC has relaxed the payment structure to offer some relief to the financially stressed sector.

Despite slump, Airtel to go ahead with Rs 20K-cr investment plan

Despite slump, Airtel to go ahead with Rs 20K-cr investment plan

Rediff.com   19 Dec 2019

Mittal said he discussed a plethora of issues with Commerce and Industry Minister Piyush Goyal and sought the government's support for faster clearances to streamline the group's investment plans.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com   19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

Delhi is crumbling under its own weight

Delhi is crumbling under its own weight

Rediff.com   18 Dec 2019

While Delhi boasts of one of the best metro systems in the world and decent infrastructure, reckless construction, legalising unauthorised colonies, and the worsening water and air quality dent its image of being a robust cosmopolitan city.